noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

New York State Office of the[...]

United States of America, et al. v. Versova Holdings, LLC, et al.-[...]
New York State Office of the[...]

Attorney General James Secures More Than 50 Million Eggs and $3.3[...]
CTIA - The Wireless Association

CTIA Files Call Center Onshoring Replies

Healthcare

Hinge Health Inc.

06/29/2026 | Press release | Distributed by Public on 06/29/2026 19:27

Statement of Changes in Beneficial Ownership (Form 4)

FORM 4

	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
	Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Insight Holdings Group, LLC

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [HNGE]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	__X__ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

(Last)

(First)

(Middle)

C/O INSIGHT PARTNERS, 1114 AVENUE OF THE AMERICAS, 36TH FLOOR

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026

(Street)

NEW YORK, NY 10036

4. If Amendment, Date Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	06/29/2026		C		732,444	A	⁽⁸⁾	732,444	I	See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		C		17,427	A	⁽⁸⁾	17,427	I	See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		C		600,613	A	⁽⁸⁾	600,613	I	See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		C		116,183	A	⁽⁸⁾	116,183	I	See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		216,787	D	$81.305⁽⁹⁾	515,657	I	See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		5,158	D	$81.305⁽⁹⁾	12,269	I	See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		177,768	D	$81.305⁽⁹⁾	422,845	I	See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		34,387	D	$81.305⁽⁹⁾	81,796	I	See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		72,672	D	$82.0479⁽¹⁰⁾	442,985	I	See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		1,729	D	$82.0479⁽¹⁰⁾	10,540	I	See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		59,592	D	$82.0479⁽¹⁰⁾	363,253	I	See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		11,528	D	$82.0479⁽¹⁰⁾	70,268	I	See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		162,965	D	$83.1765⁽¹¹⁾	280,020	I	See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		3,877	D	$83.1765⁽¹¹⁾	6,663	I	See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		133,633	D	$83.1765⁽¹¹⁾	229,620	I	See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		25,850	D	$83.1765⁽¹¹⁾	44,418	I	See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		279,671	D	$84.0207⁽¹²⁾	349	I	See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		6,654	D	$84.0207⁽¹²⁾	9	I	See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		229,334	D	$84.0207⁽¹²⁾	286	I	See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		44,363	D	$84.0207⁽¹²⁾	55	I	See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		349	D	$84.59⁽¹³⁾	0	I	See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		9	D	$84.59⁽¹³⁾	0	I	See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		286	D	$84.59⁽¹³⁾	0	I	See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		55	D	$84.59⁽¹³⁾	0	I	See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Class B Common Stock

⁽⁸⁾

06/25/2026

732,444

⁽⁸⁾

Class A Common Stock

732,444

⁽⁵⁾

3,217,008

See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾

Class B Common Stock

⁽⁸⁾

06/25/2026

17,427

⁽⁸⁾

Class A Common Stock

17,427

⁽⁵⁾

76,545

See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾

Class B Common Stock

⁽⁸⁾

06/25/2026

600,613

⁽⁸⁾

Class A Common Stock

600,613

⁽⁵⁾

2,637,985

See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾

Class B Common Stock

⁽⁸⁾

06/25/2026

116,183

⁽⁸⁾

Class A Common Stock

116,183

⁽⁵⁾

510,292

See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Insight Holdings Group, LLC C/O INSIGHT PARTNERS 1114 AVENUE OF THE AMERICAS, 36TH FLOOR NEW YORK, NY 10036		X
Insight Venture Associates X, L.P. C/O INSIGHT PARTNERS 1114 AVENUE OF THE AMERICAS, 36TH FLOOR NEW YORK, NY 10036		X
Insight Venture Associates X, Ltd. C/O INSIGHT PARTNERS 1114 AVENUE OF THE AMERICAS, 36TH FLOOR NEW YORK, NY 10036		X
Insight Venture Partners X, L.P. C/O INSIGHT PARTNERS 1114 AVENUE OF THE AMERICAS, 36TH FLOOR NEW YORK, NY 10036		X
Insight Venture Partners (Cayman) X, L.P. C/O INSIGHT PARTNERS 1114 AVENUE OF THE AMERICAS, 36TH FLOOR NEW YORK, NY 10036		X
Insight Venture Partners (Delaware) X, L.P. C/O INSIGHT PARTNERS 1114 AVENUE OF THE AMERICAS, 36TH FLOOR NEW YORK, NY 10036		X
Insight Venture Partners X (Co-Investors), L.P. C/O INSIGHT PARTNERS 1114 AVENUE OF THE AMERICAS, 36TH FLOOR NEW YORK, NY 10036		X

Signatures

Insight Venture Partners X, L.P., By: Insight Venture Associates X, L.P., its general partner, By: Insight Venture Associates X, Ltd., its general partner, By: /s/ Andrew Prodromos/Authorized Officer		06/29/2026
^**Signature of Reporting Person		Date
Insight Venture Partners (Cayman) X, L.P., By: Insight Venture Associates X, L.P., its general partner, By: Insight Venture Associates X, Ltd., its general partner, By: /s/ Andrew Prodromos/Authorized Officer		06/29/2026
^**Signature of Reporting Person		Date
Insight Venture Partners (Delaware) X, L.P., By: Insight Venture Associates X, L.P., its general partner, By: Insight Venture Associates X, Ltd., its general partner, By: /s/ Andrew Prodromos/Authorized Officer		06/29/2026
^**Signature of Reporting Person		Date
Insight Venture Partners X (Co-Investors), L.P., By: Insight Venture Associates X, L.P., its general partner, By: Insight Venture Associates X, Ltd., its general partner, By: /s/ Andrew Prodromos/Authorized Officer		06/29/2026
^**Signature of Reporting Person		Date
Insight Holdings Group, LLC, By: /s/ Andrew Prodromos/Attorney-in-Fact		06/29/2026
^**Signature of Reporting Person		Date
Insight Venture Associates X Ltd., By: /s/ Andrew Prodromos/Authorized Officer		06/29/2026
^**Signature of Reporting Person		Date
Insight Venture Associates X, L.P., By: Insight Venture Associates X, Ltd., its general partner, By: /s/ Andrew Prodromos/Authorized Officer		06/29/2026
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	See Exhibit 99.1
(2)	See Exhibit 99.1
(3)	See Exhibit 99.1
(4)	See Exhibit 99.1
(5)	See Exhibit 99.1
(6)	See Exhibit 99.1
(7)	See Exhibit 99.1
(8)	See Exhibit 99.1
(9)	See Exhibit 99.1
(10)	See Exhibit 99.1
(11)	See Exhibit 99.1
(12)	See Exhibit 99.1
(13)	See Exhibit 99.1
(14)	See Exhibit 99.1
Remarks: This Form 4 is the second of two Form 4s filed relating to the same event. The Form 4 has been split into two filings because there are more than 30 rows in Table I, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 30 rows in Table I. Each Form 4 is filed by Designated Filer, Insight Holdings Group, LLC.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

Hinge Health Inc. published this content on June 29, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 30, 2026 at 01:28 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]